Suresh Mohla, Ph.D.

Educational Background and Training

B. Sc. - Zoology (Honors), 1963, University of Delhi, India.  Ranked First in the University

M. Sc. - Zoology, 1965, University of Delhi, India.  Ranked First in the University

Ph.D. - Endocrinology, 1968, University of Delhi, India.

7/65-8/68:    Pre-doctoral Fellow - Project on Physiology of Reproduction, Department of Zoology,

              University of Delhi, India.  Supported by The Ford Foundation of America, 7/65 - 8/68.

9/68-4/70:    Post-doctoral Fellow, University of Delhi, India. Sponsored by Ministry of Health and Family

                     Planning, Government of India, and the Ford Foundation of America

5/70 -12//76: Research Associate/Assistant Professor, 1970-1976, the Ben May Laboratory for Cancer

                     Research, University of Chicago Pritzker School of Medicine, Chicago, Illinois.

Positions

1/77-8/90:    Director, Hormone Receptor Support Laboratory, Howard University Cancer Center

7/86-8/90:    Associate Director, Division of Cancer Education, Howard University Cancer Center

12/76-8/90:  Professor, of Oncology, Howard Uni9versity College of Medicine, 5/90-8/91; Associate

                    Professor, Depts of Oncology, Pharmacology, College of Medicine, and Genetics and Human                  

       Genetics, Graduate School of Arts and Sciences, 5/82 -4/90, Assistant Professor, Departments

       of Oncology, Physiology and Biophysics, and Pharmacology, 12/76 - 4/82.

8/90-5/92:    Scientific Review Administrator, Research Program Review Section, GRB, DEA, NCI

5/92-9/98:    Program Director, Cancer Biology Branch, Division of Cancer Biology, NCI

10/98-4/99:  Acting Chief, Tumor Biology Branch, Division of Cancer Biology, NCI

9/98-present: Chief, Tumor Biology and Metastasis Branch

Honors: 

• American Association of Indian Scientists in Cancer Research (AAISCR) Award 2006.
• “The Society of American Asian Scientists in Cancer Research (SAASCR) Best Achievement Award 2005:  for outstanding contribution in the field of cancer research. April 17, 2005
• NIH Merit Award, 2004.  In recognition of the DCB Think Tank Planning Committee for their planning and organization of the NCI Think Tanks in Cancer Biology series sponsored in support of the NCI strategic planning process.   
• NIH Merit Award, 2001. “For Chairing the Best Practices Subcommittee and providing strong leadership in the completion of the Best Practices Document and its successful launch on the NCI Intranet site”
• NIH Merit Award, 2001. “For leadership and exemplary efforts in preparation for the Division of Cancer Biology Sexennial Review”
• NIH Merit Award, 1997.  “For exemplary performance as a Program Director, enhancing communication with NIH and with the biomedical community”
• NCI Director’s Certificate of Appreciation, 2002.  “With appreciation for his advice leadership and dedicated service as Chair, Extramural Advisory Board, 1999-2002”
• NCI Director’s Certificate of Appreciation, 2001 “With Appreciation for your advice and dedicated service to the National Cancer Institute”
• On the Spot Award 2000. “In appreciation for his work on the Sexennial Review and his enormous efforts in coordinating the Extramural Advisory Board (EAB) activities”
• Department of Veterans Affairs, Certificate of Appreciation 1999.  “In recognition for your presentation at the First annual VHA Heart of Texas Research Symposium, April 7, 1999 at San Antonio, Texas”
• On the Spot Award, Division of Cancer Biology, 1999.  “In recognition and appreciation for your leadership in organizing and ensuring the success for the AACR Grants resource room and for participating in the AACR Grants Forum”
• Grants Administration Branch , NCI Certificate of Appreciation, 1998.  “For having significantly contributed to the National Cancer Institute Grants Orientation Workshop for the Fox Chase Cancer Center, you are hereby recognized as having been instrumental in “Demystifying the Grants Process” and presented with the certificate of appreciation”

Publications (selected list of publications)

• Peek RM, Mohla S, Dubois RN.  Inflammation in the genesis and perpetuation of cancer: summary

      and recommendations from a National Cancer Institute-sponsored meeting.  Cancer Res. 65:

      8583-8586, 2005

• Alitalo K, Mohla S and Ruoslahti E.  Lymphangiogenesis and cancer: meeting report.  Cancer Res. 64:9225-9229, 2004
• Cress AE and Mohla S. Therapeutic targeting of prostate cancer. Cancer Biol. Therap., 3:1028-1030, 2004
• Tindall D, Home FM, Hruszkewycz A, Mohla S, Shuman M, Wang Z and Kantoff P. Symposium

      on androgen action in prostate cancer.  Cancer Res. 64:7178-7180, 2004

• Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA and Mohla S. Head and neck cancer: meeting

      summary and research opportunities. Cancer Res.  64:8126-8129, 2004

• Mohla S. Under-investigated area in prostate cancer: Cross talk between the bone microenvironment

      and prostate cancer bone metastasis (Guest Editor). J Cell Biochem. 91:684-685, 2004

• Mohla S. The biology of skeletal metastases (Foreword), Evan T Keller and Leland WK Chung,

      Editors,, Kluwer Acad Publ, Boston, 2004.

• Carver L, Schnitzer JE, Anderson RG, Mohla S. Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res. 63:6571-6574, 2003.
• Matrisian LM, Sledge GWJr, Mohla S. Extracellular proteolysis and cancer: meeting summary and future

      directions. Cancer Res. 63:6105-6109, 2003.

• Reddi AH, Roodman D, Freeman C, Mohla S.  Mechanisms of tumor metastasis to the bone: challenges and research Opportunities.  J Bone Mineral Res. 18:190-194, 2003.
• Parsons JT, Zetter B, Mohla S.  Shifting paradigms in tumor metastasis: challenges and opportunities.

      Cancer Biol. Therapy 1:582-585, 2002.

• Herlyn M, Padarathsingh M, Chin L, Hendrix M, Becker D, Nelson M, DeClerck Y, McCarthy J, Mohla S. New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.  Am J Pathol. 161:1949-1957, 2002.
• Herlyn M, Ferrone S, Ronai Z, Finerty J, Pelroy R, Mohla S.  Melanoma Biology and Progression. Cancer Res 61:4642-4643, 2001
• Matrisian L, Cunha GR and Mohla S:  Epithelial-stromal interactions and tumor progression: Meeting summary and future Directions.  Cancer Res 61:3844-3846, 2001.
• Asseffa A, L A Dickson, S Mohla, T A Bremner. Phorbol Myristate Acetate- Differentiated THP-1 Cells Display Increased Levels of MHC Class I and Class 11 mRNA and Interferon-((-inducible Tumoricidal  Activity.  Oncol Res 5:11-18, 1993.
• Ahir S and S Mohla: Regulation of renal N-nitrosodimethylamine demethylase activity by androgens,  progestins, glucocorticoids and estrogen in BALB/c mice. Cancer Research 49:3737-3741, 1989.
• Mohla S, C Sampson, T Khan, J P Enterline, L Leffall Jr. and J E White.  Estrogen and progesterone receptors in breast cancer in black Americans- correlation of receptor data with tumor differentiation.  Cancer 50:552-559, 1982.
• DeSombre E R, S Mohla and E V Jensen. Receptor transformation, the key to estrogen action. J Steroid Biochem. 6:469-473, 1975.

Participation in National and International Symposia, Workshops and Think Tanks

• Symposium Executive Chair, 2006; 5^th Intl Sym on Hormonal Carcinogenesis, Montpellier, France
• Member of the Board, Society of Melanoma Research, 2004- 2007
• Member, Scientific Advisory Board, Intl Sym on Hormonal Carcinogenesis, 2002- present
• Session Chair, “Funding Opportunities for Angiogenesis Research at the NIH” at the AACR meeting on Anti-angiogenesis and Drug Delivery to Tumors: Bench to Bedside. Nov 9-13, 2005, Boston,
• Speaker, NCI Listens, AACR annual Meeting 2005
• Member, Selection Committee for the AACR-WICR-Charlotte Friend Memorial Lectureship, 2004-05
• Member, AACR Program Committee, 2004-05; Member of Subcommittee on Tumor Biology; Section on Angiogenesis, Microcirculation and the Cellular Microenvironment
• Member, Program Committee, Intl Meetings on Epithelio-Mesenchymal Transition, 2002 –present 
• Co-chair, Scientific Organizing Committee, Prouts Neck Meet. on Prostate Cancer, 2001-present
• Member, International Advisory Committee, 3rd International Conference on Tumor Microenvironment:

             Progression, Therapy and Prevention, Prague, 2003

• Member, Scientific Program Committee, 10th Intl Cong Metastasis Res Soc, Genoa, Italy, 09/2004
• Member, Organizing Comm. Intl Conf on Tumor Progression and Therapeutic Resistance, 2004-06
• Member, Scientific Committee, symposia on Cancer Induced Bone Diseases, 2002-2006
• Tumor Dormancy Think Tank, Co-chairs: Robert Vessella and Klaus Pantel, July 12-14, 2006
• Inflammation and Cancer Think Tank, Chairs: R Dubois and G Dranoff,  June 2-4, 2004
• Head and Neck Cancer Workshop: Research Opportunities, Co-chairs: Jennifer Grandis, Jennifer Pietenpol, Joel Greenberger, May 24-26, 2004, Washington, DC
• Lymphangiogenesis and Cancer Workshop, April 21-23, 2004, Washington, DC 

Symposium on Androgen Action in Prostate Cancer, March 4-6, 2004, Keystone, CO (Jointly sponsored by the SPORE program and DCB)           

• Tumor Microenvironment Think Tank, Co-chairs: Joan Brugge and David Roodman, Nov 2003
• Extracellular proteolysis and cancer. Co-chairs: Lynn Matrisian and George Sledge, Nov 2002
• Role of caveolae and lipid rafts in cancer. Co-chairs: Jan Schnitzer and Richard Anderson, 03/2002
• New approaches to the biology of melanoma: a workshop of the NIH Pathology B Study Section, Keystone, CO, January 2002
• Shifting Paradigms in Tumor Metastasis, Co-chairs: Tom Parsons & Bruce Zetter, November 2001
• Mechanisms of Tumor Metastasis to the Bone: Challenges and Opportunities, Co-chairs: A. Hari Reddi  and David Roodman, November 2000
• Melanoma Biology and Progression Workshop. Co-chairs: M Herlyn, S Ferrone, Z Ronai, November 2000 
• Epithelial-Stromal Interaction and Tumor Progression workshop, Co-chairs:  Lynn Matrisian and Gerald Cunha, September 2000

NIH- and NCI Wide Committees

• Member, Melanoma Focus Group, sponsored by NCI and Society of Melanoma Research 2005
• Member, Steering Committee, Trans-Institute Angiogenesis Research Program (TARP), 2004-present
• Member, Trans NIH Working Group on Lymphatics Research, 2003-present
• NCI Liaison, Congressional Significant Items on Cancer Metastasis, 2001-2005